Published in N Engl J Med on March 15, 2010
RAte Control Efficacy in Permanent Atrial Fibrillation | NCT00392613
Rate Control in Atrial Fibrillation II (RATAFII) | NCT02695992
Direct or coincidental elimination of stable rotors or focal sources may explain successful atrial fibrillation ablation: on-treatment analysis of the CONFIRM trial (Conventional ablation for AF with or without focal impulse and rotor modulation). J Am Coll Cardiol (2013) 2.58
Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial. Eur Heart J (2013) 1.99
Atrial fibrillation ablation outcome is predicted by left atrial remodeling on MRI. Circ Arrhythm Electrophysiol (2013) 1.96
Symptoms and functional status of patients with atrial fibrillation: state of the art and future research opportunities. Circulation (2012) 1.67
Management of atrial fibrillation by primary care physicians in Germany: baseline results of the ATRIUM registry. Clin Res Cardiol (2011) 1.58
Initial independent outcomes from focal impulse and rotor modulation ablation for atrial fibrillation: multicenter FIRM registry. J Cardiovasc Electrophysiol (2014) 1.53
Effect of dronedarone on clinical end points in patients with atrial fibrillation and coronary heart disease: insights from the ATHENA trial. Europace (2013) 1.42
Ablation of rotor and focal sources reduces late recurrence of atrial fibrillation compared with trigger ablation alone: extended follow-up of the CONFIRM trial (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation). J Am Coll Cardiol (2014) 1.42
Ablation of atrial fibrillation. Trends Cardiovasc Med (2014) 1.41
[Commentary to the article: Van Gelder IC, Groenveld HF, Crijns HJ et al. Lenient versus strict rate control in patients with atrial fibrillation]. Kardiol Pol (2010) 1.38
Archetype, adaptation and the mammalian heart. Neth Heart J (2011) 1.08
Impact of atrial fibrillation on exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary study. Circ Heart Fail (2013) 1.00
2014 AATS guidelines for the prevention and management of perioperative atrial fibrillation and flutter for thoracic surgical procedures. J Thorac Cardiovasc Surg (2014) 0.99
American Heart Association atrial fibrillation research summit: a conference report from the American Heart Association. Circulation (2011) 0.97
A clinician's guide to the assessment and interpretation of noninferiority trials for novel therapies. Open Med (2014) 0.97
Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study. Circ Arrhythm Electrophysiol (2014) 0.94
Rate control in atrial fibrillation. N Engl J Med (2010) 0.90
Comparison of Atrial Fibrillation in the Young versus That in the Elderly: A Review. Cardiol Res Pract (2013) 0.90
Arrhythmia-Induced Cardiomyopathies: Mechanisms, Recognition, and Management. J Am Coll Cardiol (2015) 0.88
Rate-control versus rhythm-control strategies and outcomes in septuagenarians with atrial fibrillation. Am J Med (2013) 0.87
Rationale and current perspective for early rhythm control therapy in atrial fibrillation. Europace (2011) 0.87
Risk factors for bradycardia requiring pacemaker implantation in patients with atrial fibrillation. Am J Cardiol (2012) 0.86
Rate versus rhythm control in atrial fibrillation. Can Fam Physician (2013) 0.86
Stroke prevention in atrial fibrillation: concepts and controversies. Curr Cardiol Rev (2012) 0.86
Atrial fibrillation in heart failure: what should we do? Eur Heart J (2015) 0.86
Health-related quality of life changes in patients undergoing repeated catheter ablation for atrial fibrillation. Clin Res Cardiol (2015) 0.85
Rate control management of atrial fibrillation: may a mathematical model suggest an ideal heart rate? PLoS One (2015) 0.85
Diagnostic accuracy of NT-proBNP ratio (BNP-R) for early diagnosis of tachycardia-mediated cardiomyopathy: a pilot study. Clin Res Cardiol (2011) 0.85
Effect of bucindolol on heart failure outcomes and heart rate response in patients with reduced ejection fraction heart failure and atrial fibrillation. Eur J Heart Fail (2012) 0.84
RHYTHM-AF: design of an international registry on cardioversion of atrial fibrillation and characteristics of participating centers. BMC Cardiovasc Disord (2012) 0.83
Drug therapy for heart failure in older patients-what do they want? J Geriatr Cardiol (2015) 0.82
Atrial Fibrillation and Race - A Contemporary Review. Curr Cardiovasc Risk Rep (2013) 0.80
A genome-wide association study to identify genomic modulators of rate control therapy in patients with atrial fibrillation. Am J Cardiol (2014) 0.79
Atrial fibrillation in 2010: advances in treatment and management. Nat Rev Cardiol (2011) 0.79
Rate control in atrial fibrillation, insight into the RACE II study. Neth Heart J (2013) 0.79
Increased Heart Rate Is Associated With Higher Mortality in Patients With Atrial Fibrillation (AF): Results From the Outcomes Registry for Better Informed Treatment of AF (ORBIT-AF). J Am Heart Assoc (2015) 0.79
Racial Differences in Atrial Fibrillation-Related Cardiovascular Disease and Mortality: The Atherosclerosis Risk in Communities (ARIC) Study. JAMA Cardiol (2016) 0.79
Appreciating the medical literature: five notable articles in general internal medicine from 2009 and 2010. Open Med (2011) 0.78
Clinical characteristics, management, and control of permanent vs. nonpermanent atrial fibrillation: insights from the RealiseAF survey. PLoS One (2014) 0.78
Risk-benefit ratio assessment for stroke prevention in intermediate risk atrial fibrillation patients: will TEE-based aspirin treatment fill the gap? Neth Heart J (2011) 0.78
Managing atrial fibrillation. Ann Emerg Med (2015) 0.78
Rotors as drivers of atrial fibrillation and targets for ablation. Curr Cardiol Rep (2014) 0.77
Cost considerations in the management of atrial fibrillation - impact of dronedarone. Clinicoecon Outcomes Res (2012) 0.77
Identification of genomic loci associated with resting heart rate and shared genetic predictors with all-cause mortality. Nat Genet (2016) 0.77
Outcomes after nonemergent electrical cardioversion for atrial arrhythmias. Am J Cardiol (2015) 0.76
A Computational Study on the Relation between Resting Heart Rate and Atrial Fibrillation Hemodynamics under Exercise. PLoS One (2017) 0.76
Heart rate is associated with progression of atrial fibrillation, independent of rhythm. Heart (2015) 0.76
Lenient versus strict rate control in atrial fibrillation. N Engl J Med (2010) 0.75
Lenient versus strict rate control in atrial fibrillation. N Engl J Med (2010) 0.75
Atrial Fibrillation In Heart Failure: New Directions In Diagnosis, Risk Assessment And Risk Reduction. J Atr Fibrillation (2014) 0.75
Dronedarone: evidence supporting its therapeutic use in the treatment of atrial fibrillation. Core Evid (2010) 0.75
The burden of proof: The current state of atrial fibrillation prevention and treatment trials. Heart Rhythm (2017) 0.75
An International Observational Prospective Survey Assessing the Control of Atrial Fibrillation in Asia-Pacific: Results of the Record-AFAP Registry. Clin Med Insights Cardiol (2015) 0.75
Management of Atrial Fibrillation in Pregnancy. J Atr Fibrillation (2010) 0.75
The current approach of atrial fibrillation management. Avicenna J Med (2016) 0.75
Electrophysiology and heart rhythm disorders in older adults. J Geriatr Cardiol (2016) 0.75
Atrial fibrillation. Ulster Med J (2013) 0.75
Fast atrial fibrillation and caecal volvulus--a case report and evidence based management. BMJ Case Rep (2011) 0.75
PURLS: A-fib and rate control: don't go too low. J Fam Pract (2010) 0.75
Is SYNTAX Score Predictive of Atrial Fibrillation after On-Pump Coronary Artery Bypass Graft Surgery? Korean Circ J (2016) 0.75
ACP Journal Club. Lenient rate control is as effective as strict rate control for preventing cardiovascular events in AF. Ann Intern Med (2010) 0.75
The clinical, electrocardiographic and echocardiographic characteristics and long-term outcome of patients with tachycardia-induced cardiomyopathy. Cardiovasc J Afr (2012) 0.75
What tissue does circumferential PV Isolation actually modulate? J Cardiovasc Electrophysiol (2013) 0.75
Atrial fibrillation in heart failure: drug therapies for rate and rhythm control. Heart Fail Rev (2014) 0.75
Atrial fibrillation. J Biomed Res (2013) 0.75
Medication management of atrial fibrillation: emerging therapies for rhythm control and stroke prevention. P T (2011) 0.75
Heartbeat Cycle Length Detection by a Ballistocardiographic Sensor in Atrial Fibrillation and Sinus Rhythm. Biomed Res Int (2015) 0.75
Effects of pharmacologic therapy on health-related quality of life in elderly patients with atrial fibrillation: a systematic review of randomized and nonrandomized trials. Clin Med Insights Cardiol (2013) 0.75
Atrial Fibrillation as a Prognostic Indicator in Medium to Large-Sized Dogs with Myxomatous Mitral Valvular Degeneration and Congestive Heart Failure. J Vet Intern Med (2015) 0.75
Lenient versus strict rate control in atrial fibrillation. N Engl J Med (2010) 0.75
Relationship between exercise induced elevation of left ventricular filling pressure and exercise intolerance in patients with atrial fibrillation. J Geriatr Cardiol (2016) 0.75
Rate control in atrial fibrillation by cooling: effect of temperature on dromotropy in perfused rabbit hearts. Cardiol Res Pract (2011) 0.75
Efficacy of Intravenous Administration of Landiolol in Patients With Acute Heart Failure and Supraventricular Tachyarrhythmia. J Clin Med Res (2017) 0.75
Management of patients with atrial fibrillation: specific considerations for the old age. Cardiol Res Pract (2011) 0.75
HRS policy statement: clinical cardiac electrophysiology fellowship curriculum: update 2011. Heart Rhythm (2011) 0.75
Management of tachycardia. F1000Prime Rep (2015) 0.75
Management Of Atrial Fibrillation In Patients With Heart Failure. J Atr Fibrillation (2014) 0.75
Symptoms In Atrial Fibrillation: A Contemporary Review And Future Directions. J Atr Fibrillation (2016) 0.75
Oral carvedilol in escalating doses in the acute treatment of atrial fibrillation. J Pharmacol Pharmacother (2014) 0.75
The prognostic effects of ventricular heart rate among patients with permanent atrial fibrillation with and without coronary artery disease: a multicenter prospective observational study. Medicine (Baltimore) (2015) 0.75
CHA2DS2-VASc Score and Heart Rate Predict Ischemic Stroke Outcomes in Patients withAtrial Fibrillation. Zhonghua Minguo Xin Zang Xue Hui Za Zhi (2014) 0.75
The reversal of cardiology practices: interventions that were tried in vain. Cardiovasc Diagn Ther (2013) 0.75
Almanac 2011: Cardiac Arrhythmias and Pacing. The National Society Journals Present Selected Research that has Driven Recent Advances in Clinical Cardiology. Mater Sociomed (2011) 0.75
In permanent atrial fibrillation, lenient rate control is not inferior to strict rate control for preventing cardiovascular morbidity and mortality. Evid Based Med (2010) 0.75
Atrial fibrillation management in older heart failure patients: a complex clinical problem. Heart Int (2016) 0.75
Heart rate-induced modifications of concentric left ventricular hypertrophy: exploration of a novel therapeutic concept. Am J Physiol Heart Circ Physiol (2016) 0.75
Atrial fibrillation in heart failure: The sword of Damocles revisited. World J Cardiol (2013) 0.75
Current issues in atrial fibrillation. ISRN Cardiol (2012) 0.75
Current Evidence and Recommendations for Rate Control in Atrial Fibrillation. Arrhythm Electrophysiol Rev (2013) 0.75
Association of atrial fibrillation risk alleles and response to acute rate control therapy. Am J Emerg Med (2016) 0.75
Who Needs Pharmacologic Therapy? J Atr Fibrillation (2014) 0.75
Recent Atrial Fibrillation Guidelines - Looking at Both Sides of the Atlantic. Arrhythm Electrophysiol Rev (2013) 0.75
Relation Between RR Intervals and Early Diastolic Mitral Annular Velocities in Atrial Fibrillation. Korean Circ J (2012) 0.75
Rate versus rhythm in atrial fibrillation: and how slow do you go? Can Fam Physician (2011) 0.75
Should rhythm control be preferred in younger atrial fibrillation patients? J Interv Card Electrophysiol (2012) 0.75
Atrioventricular junction ablation and pacemaker implantation for heart failure associated with atrial fibrillation: potential issues and therapies in the setting of acute heart failure syndrome. Heart Fail Rev (2011) 0.75
[Medicinal rate control in atrial fibrillation]. Herzschrittmacherther Elektrophysiol (2014) 0.75
The ABC pathway: an integrated approach to improve AF management. Nat Rev Cardiol (2017) 0.75
Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med (2013) 20.65
A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest (2010) 10.29
Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med (2002) 8.72
Effect of dronedarone on cardiovascular events in atrial fibrillation. N Engl J Med (2009) 8.51
A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med (2002) 8.37
Early invasive versus selectively invasive management for acute coronary syndromes. N Engl J Med (2005) 7.80
Rosuvastatin in older patients with systolic heart failure. N Engl J Med (2007) 7.55
Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int (2004) 6.32
Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis. Psychosom Med (2004) 6.00
Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter. N Engl J Med (2007) 5.78
Apixaban with antiplatelet therapy after acute coronary syndrome. N Engl J Med (2011) 4.81
Prasugrel versus clopidogrel for acute coronary syndromes without revascularization. N Engl J Med (2012) 4.49
Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation. Eur Heart J (2005) 4.46
Effects of antidepressant treatment following myocardial infarction. Br J Psychiatry (2007) 4.44
Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: a prospective, randomized trial. Crit Care Med (2002) 4.33
Global incidences of out-of-hospital cardiac arrest and survival rates: Systematic review of 67 prospective studies. Resuscitation (2010) 3.98
Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J (2005) 3.89
Culprit vessel only versus multivessel and staged percutaneous coronary intervention for multivessel disease in patients presenting with ST-segment elevation myocardial infarction: a pairwise and network meta-analysis. J Am Coll Cardiol (2011) 3.66
B-type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction. J Am Coll Cardiol (2013) 3.54
Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study. Clin Res Cardiol (2010) 3.50
Intensive glucose regulation in hyperglycemic acute coronary syndrome: results of the randomized BIOMarker study to identify the acute risk of a coronary syndrome-2 (BIOMArCS-2) glucose trial. JAMA Intern Med (2013) 3.46
Plasma concentration of amino-terminal pro-brain natriuretic peptide in chronic heart failure: prediction of cardiovascular events and interaction with the effects of rosuvastatin: a report from CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure). J Am Coll Cardiol (2009) 3.32
Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. J Am Coll Cardiol (2009) 3.31
Thrombin-receptor antagonist vorapaxar in acute coronary syndromes. N Engl J Med (2011) 3.20
A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines? Eur Heart J (2009) 3.06
Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction. Circulation (2004) 3.05
Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. Nat Genet (2012) 3.04
Presence of older thrombus is an independent predictor of long-term mortality in patients with ST-elevation myocardial infarction treated with thrombus aspiration during primary percutaneous coronary intervention. Circulation (2008) 2.96
Diagnostic accuracy of combined intracoronary pressure and flow velocity information during baseline conditions: adenosine-free assessment of functional coronary lesion severity. Circ Cardiovasc Interv (2012) 2.93
Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol (2005) 2.93
Randomized trial comparing same-day discharge with overnight hospital stay after percutaneous coronary intervention: results of the Elective PCI in Outpatient Study (EPOS). Circulation (2007) 2.90
Chronic vagus nerve stimulation: a new and promising therapeutic approach for chronic heart failure. Eur Heart J (2010) 2.86
Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: do lamin A/C mutations portend a high risk of sudden death? J Mol Med (Berl) (2004) 2.81
Worsening renal function and prognosis in heart failure: systematic review and meta-analysis. J Card Fail (2007) 2.77
Two-year clinical outcomes of Absorb bioresorbable vascular scaffold implantation in complex coronary artery disease patients stratified by SYNTAX score and ABSORB II study enrolment criteria. EuroIntervention (2016) 2.67
Anemia and mortality in heart failure patients a systematic review and meta-analysis. J Am Coll Cardiol (2008) 2.59
Progression from paroxysmal to persistent atrial fibrillation clinical correlates and prognosis. J Am Coll Cardiol (2010) 2.59
A single dose of erythropoietin in ST-elevation myocardial infarction. Eur Heart J (2010) 2.52
Management of chronic heart failure guided by individual N-terminal pro-B-type natriuretic peptide targets: results of the PRIMA (Can PRo-brain-natriuretic peptide guided therapy of chronic heart failure IMprove heart fAilure morbidity and mortality?) study. J Am Coll Cardiol (2010) 2.50
Cardiac involvement in patients with pulmonary sarcoidosis assessed at two university medical centers in the Netherlands. Chest (2005) 2.50
Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis. Eur Heart J (2013) 2.45
Aortic stiffness and diameter predict progressive aortic dilatation in patients with Marfan syndrome. Eur Heart J (2004) 2.44
Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention. N Engl J Med (2006) 2.42
EAE/ASE recommendations for image acquisition and display using three-dimensional echocardiography. J Am Soc Echocardiogr (2012) 2.41
Ultrasound and microbubble-targeted delivery of macromolecules is regulated by induction of endocytosis and pore formation. Circ Res (2009) 2.41
Symptom dimensions of depression following myocardial infarction and their relationship with somatic health status and cardiovascular prognosis. Am J Psychiatry (2006) 2.41
Drawbacks and prognostic value of formulas estimating renal function in patients with chronic heart failure and systolic dysfunction. Circulation (2006) 2.35
Microalbuminuria and risk of venous thromboembolism. JAMA (2009) 2.35
Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND. Eur Heart J (2013) 2.32
Thrombospondin-2 is essential for myocardial matrix integrity: increased expression identifies failure-prone cardiac hypertrophy. Circ Res (2004) 2.31
Comparison between the prognostic value of left ventricular function and myocardial perfusion reserve in patients with ischemic heart disease. J Nucl Med (2009) 2.31
Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria. Circulation (2004) 2.30
Design and methodology of the COACH study: a multicenter randomised Coordinating study evaluating Outcomes of Advising and Counselling in Heart failure. Eur J Heart Fail (2004) 2.30
Relationship between left ventricular dysfunction and depression following myocardial infarction: data from the MIND-IT. Eur Heart J (2005) 2.28
Arterial stiffness increases with deteriorating glucose tolerance status: the Hoorn Study. Circulation (2003) 2.28
Effect of moderate or intensive disease management program on outcome in patients with heart failure: Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH). Arch Intern Med (2008) 2.23
Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction. Ann Med (2010) 2.21
Dabigatran vs. placebo in patients with acute coronary syndromes on dual antiplatelet therapy: a randomized, double-blind, phase II trial. Eur Heart J (2011) 2.21
Effect of lenient versus strict rate control on cardiac remodeling in patients with atrial fibrillation data of the RACE II (RAte Control Efficacy in permanent atrial fibrillation II) study. J Am Coll Cardiol (2011) 2.19
Prognostic value of coronary blood flow velocity and myocardial perfusion in intermediate coronary narrowings and multivessel disease. J Am Coll Cardiol (2002) 2.18
Who is at risk of post-MI depressive symptoms? J Psychosom Res (2005) 2.18
Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta-analysis of individual patient data. J Am Coll Cardiol (2010) 2.17
Atrial fibrillation and heart failure in cardiology practice: reciprocal impact and combined management from the perspective of atrial fibrillation: results of the Euro Heart Survey on atrial fibrillation. J Am Coll Cardiol (2009) 2.16
Effect of rate or rhythm control on quality of life in persistent atrial fibrillation. Results from the Rate Control Versus Electrical Cardioversion (RACE) Study. J Am Coll Cardiol (2004) 2.10
Continuous vs episodic prophylactic treatment with amiodarone for the prevention of atrial fibrillation: a randomized trial. JAMA (2008) 2.09
Rate control efficacy in permanent atrial fibrillation: successful and failed strict rate control against a background of lenient rate control: data from RACE II (Rate Control Efficacy in Permanent Atrial Fibrillation). J Am Coll Cardiol (2013) 2.08
Preprocedural C-reactive protein is not associated with angiographic restenosis or target lesion revascularization after coronary artery stent placement. Clin Chem (2004) 2.08
Percutaneous coronary intervention with off-site cardiac surgery backup for acute myocardial infarction as a strategy to reduce door-to-balloon time. Am J Cardiol (2007) 2.03
General anesthesia with sevoflurane decreases myocardial blood volume and hyperemic blood flow in healthy humans. Anesth Analg (2013) 2.01
Impact of onsite or dispatched automated external defibrillator use on survival after out-of-hospital cardiac arrest. Circulation (2011) 2.01
Importance of the first link: description and recognition of an out-of-hospital cardiac arrest in an emergency call. Circulation (2009) 2.00